Lisa E.S. Crose

876 total citations
13 papers, 687 citations indexed

About

Lisa E.S. Crose is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cell Biology. According to data from OpenAlex, Lisa E.S. Crose has authored 13 papers receiving a total of 687 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Pulmonary and Respiratory Medicine and 6 papers in Cell Biology. Recurrent topics in Lisa E.S. Crose's work include Sarcoma Diagnosis and Treatment (6 papers), Hippo pathway signaling and YAP/TAZ (6 papers) and Cancer-related gene regulation (4 papers). Lisa E.S. Crose is often cited by papers focused on Sarcoma Diagnosis and Treatment (6 papers), Hippo pathway signaling and YAP/TAZ (6 papers) and Cancer-related gene regulation (4 papers). Lisa E.S. Crose collaborates with scholars based in United States. Lisa E.S. Crose's co-authors include Corinne M. Linardic, Brian Belyea, Rex C. Bentley, Frederic G. Barr, Gary L. Johnson, Thomas L. Hilder, Noah Sciaky, Stephen Safe, Jing Li and Erik Hedrick and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and PLoS ONE.

In The Last Decade

Lisa E.S. Crose

13 papers receiving 684 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lisa E.S. Crose United States	13	425	234	194	141	112	13	687
Clare F. Malone United States	9	302 0.7×	85 0.4×	65 0.3×	85 0.6×	83 0.7×	10	487
Oriol Arqués Spain	9	578 1.4×	106 0.5×	72 0.4×	237 1.7×	126 1.1×	11	762
David Herrero‐Martín Spain	12	289 0.7×	181 0.8×	61 0.3×	140 1.0×	109 1.0×	12	467
JulieAnn Rader United States	6	304 0.7×	165 0.7×	58 0.3×	259 1.8×	136 1.2×	8	542
Carrie R. Graveel United States	11	419 1.0×	86 0.4×	52 0.3×	201 1.4×	110 1.0×	21	635
Galina Semenova United States	7	418 1.0×	48 0.2×	100 0.5×	227 1.6×	91 0.8×	7	579
Greg Foltz United States	11	502 1.2×	82 0.4×	55 0.3×	155 1.1×	208 1.9×	19	725
Elvira V. Grigorieva Russia	18	466 1.1×	87 0.4×	318 1.6×	115 0.8×	174 1.6×	45	715
Lanping Quan China	17	565 1.3×	74 0.3×	131 0.7×	210 1.5×	179 1.6×	21	774
D A E Parolin Canada	9	308 0.7×	119 0.5×	55 0.3×	144 1.0×	161 1.4×	12	475

Countries citing papers authored by Lisa E.S. Crose

Since Specialization

Citations

This map shows the geographic impact of Lisa E.S. Crose's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa E.S. Crose with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa E.S. Crose more than expected).

Fields of papers citing papers by Lisa E.S. Crose

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisa E.S. Crose. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa E.S. Crose. The network helps show where Lisa E.S. Crose may publish in the future.

Co-authorship network of co-authors of Lisa E.S. Crose

This figure shows the co-authorship network connecting the top 25 collaborators of Lisa E.S. Crose. A scholar is included among the top collaborators of Lisa E.S. Crose based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisa E.S. Crose. Lisa E.S. Crose is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Crose, Lisa E.S., et al.. (2018). The Transcriptional Coactivator TAZ Is a Potent Mediator of Alveolar Rhabdomyosarcoma Tumorigenesis. Clinical Cancer Research. 24(11). 2616–2630. 17 indexed citations

Crose, Lisa E.S., Rex C. Bentley, Yi-Tzu Lin, et al.. (2018). Loss of MST/Hippo Signaling in a Genetically Engineered Mouse Model of Fusion-Positive Rhabdomyosarcoma Accelerates Tumorigenesis. Cancer Research. 78(19). 5513–5520. 15 indexed citations

Crose, Lisa E.S., et al.. (2017). A Novel Notch–YAP Circuit Drives Stemness and Tumorigenesis in Embryonal Rhabdomyosarcoma. Molecular Cancer Research. 15(12). 1777–1791. 51 indexed citations

Crose, Lisa E.S., et al.. (2015). Secreted Frizzled-Related Protein 3 (SFRP3) Is Required for Tumorigenesis of PAX3–FOXO1-Positive Alveolar Rhabdomyosarcoma. Clinical Cancer Research. 21(21). 4868–4880. 20 indexed citations

Hedrick, Erik, Lisa E.S. Crose, Corinne M. Linardic, & Stephen Safe. (2015). Histone Deacetylase Inhibitors Inhibit Rhabdomyosarcoma by Reactive Oxygen Species–Dependent Targeting of Specificity Protein Transcription Factors. Molecular Cancer Therapeutics. 14(9). 2143–2153. 49 indexed citations

Crose, Lisa E.S., et al.. (2015). Role of the YAP Oncoprotein in Priming Ras-Driven Rhabdomyosarcoma. PLoS ONE. 10(10). e0140781–e0140781. 44 indexed citations

Li, Jing, et al.. (2015). A Review: Molecular Aberrations within Hippo Signaling in Bone and Soft-Tissue Sarcomas. Frontiers in Oncology. 5. 190–190. 59 indexed citations

Crose, Lisa E.S., et al.. (2013). Human Rhabdomyosarcoma Cell Lines for Rhabdomyosarcoma Research: Utility and Pitfalls. Frontiers in Oncology. 3. 183–183. 138 indexed citations

Crose, Lisa E.S., Kathleen A. Galindo, Julien Fitamant, et al.. (2013). Alveolar rhabdomyosarcoma–associated PAX3-FOXO1 promotes tumorigenesis via Hippo pathway suppression. Journal of Clinical Investigation. 124(1). 285–296. 98 indexed citations

10.

Crose, Lisa E.S., Katherine T. Etheridge, Brian Belyea, et al.. (2012). FGFR4 Blockade Exerts Distinct Antitumorigenic Effects in Human Embryonal versus Alveolar Rhabdomyosarcoma. Clinical Cancer Research. 18(14). 3780–3790. 57 indexed citations

11.

Chadalapaka, Gayathri, Indira Jutooru, Sandeep Sreevalsan, et al.. (2012). Inhibition of rhabdomyosarcoma cell and tumor growth by targeting specificity protein (Sp) transcription factors. International Journal of Cancer. 132(4). 795–806. 36 indexed citations

12.

Crose, Lisa E.S. & Corinne M. Linardic. (2011). Receptor Tyrosine Kinases as Therapeutic Targets in Rhabdomyosarcoma. Sarcoma. 2011. 1–11. 32 indexed citations

13.

Crose, Lisa E.S., Thomas L. Hilder, Noah Sciaky, & Gary L. Johnson. (2009). Cerebral Cavernous Malformation 2 Protein Promotes Smad Ubiquitin Regulatory Factor 1-mediated RhoA Degradation in Endothelial Cells. Journal of Biological Chemistry. 284(20). 13301–13305. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact